title: Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.
abstract: Leukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement.
authors.affiliation: Department of Pediatric Infectious Disease, Ondokuz Mayıs University, Samsun, Turkey.
authors.forename: Gülhadiye
authors.initials: G
authors.lastname: Avcu
authors.forename: Gülnar
authors.initials: G
authors.lastname: Sensoy
authors.forename: Mehmet Halil
authors.initials: MH
authors.lastname: Çeliksoy
authors.forename: Ayhan
authors.initials: A
authors.lastname: Sogut
authors.forename: Mehmet
authors.initials: M
authors.lastname: Kefeli
authors.forename: Arzu
authors.initials: A
authors.lastname: Karli
authors.forename: Nursen
authors.initials: N
authors.lastname: Belet
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects*; D001706:Biopsy; D002648:Child; D005260:Female; D006801:Humans; D012867:Skin / Q000473:pathology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000995:Antitubercular Agents
keywords: anti-tuberculosis drug; ethambutol; leukocytoclastic vasculitis; rifampicin